Humana Inc. (NYSE:HUM) Shares Sold by Truist Financial Corp

Truist Financial Corp trimmed its position in Humana Inc. (NYSE:HUM - Free Report) by 29.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,479 shares of the insurance provider's stock after selling 4,733 shares during the period. Truist Financial Corp's holdings in Humana were worth $5,255,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in HUM. Morgan Stanley raised its stake in Humana by 6.2% during the third quarter. Morgan Stanley now owns 2,040,896 shares of the insurance provider's stock valued at $992,938,000 after buying an additional 119,760 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of Humana by 35.9% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider's stock worth $741,409,000 after purchasing an additional 402,559 shares during the last quarter. Northern Trust Corp grew its position in Humana by 5.1% during the 3rd quarter. Northern Trust Corp now owns 1,327,489 shares of the insurance provider's stock valued at $645,850,000 after purchasing an additional 64,245 shares during the last quarter. Invesco Ltd. raised its holdings in Humana by 1.4% in the third quarter. Invesco Ltd. now owns 965,488 shares of the insurance provider's stock worth $469,729,000 after buying an additional 13,670 shares during the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of Humana by 39.3% during the third quarter. AQR Capital Management LLC now owns 681,868 shares of the insurance provider's stock valued at $331,743,000 after buying an additional 192,546 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

Several research firms recently issued reports on HUM. Raymond James began coverage on Humana in a research report on Friday, March 22nd. They issued a "market perform" rating on the stock. Mizuho reduced their price target on shares of Humana from $550.00 to $400.00 and set a "buy" rating for the company in a research note on Friday, January 26th. UBS Group lowered their price objective on shares of Humana from $334.00 to $326.00 and set a "neutral" rating on the stock in a research report on Thursday, April 25th. Truist Financial reiterated a "hold" rating and set a $550.00 target price on shares of Humana in a research note on Friday, January 19th. Finally, TD Cowen cut their price objective on Humana from $427.00 to $396.00 and set a "buy" rating for the company in a report on Tuesday, April 2nd. Eleven equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $424.50.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the firm's stock in a transaction that occurred on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.29% of the company's stock.

Humana Price Performance

Shares of NYSE HUM traded down $1.31 during mid-day trading on Monday, reaching $319.23. The company's stock had a trading volume of 1,406,323 shares, compared to its average volume of 1,985,492. The stock has a fifty day moving average of $323.55 and a two-hundred day moving average of $387.14. The firm has a market capitalization of $38.47 billion, a PE ratio of 19.88, a P/E/G ratio of 1.86 and a beta of 0.49. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $541.21. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company's quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $9.38 earnings per share. As a group, sell-side analysts anticipate that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Friday, June 28th. Humana's payout ratio is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.